Table 3 Comparison of patients group with para-aortic lymph node surgery
From: Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer
Tumor removal and/or para-aortic biopsy N = 14 (70.0%) | Para-aortic lymphadenectomy N = 6 (30.0%) | p | |
|---|---|---|---|
Countrya | |||
Mexico (INCan) | 5 (35.7) | 2 (33.3) | 0.26 |
Colombia (ICLA) | 9 (64.3) | 4 (66.7) | |
Age (years)b | 45 (40–45) | 44.5 (42–50) | 0.90 |
BMIb | 26.55 (23.7–28.3) | 23.9 (22.5–32.7) | 0.60 |
Histologya | |||
Squamous | 6 (42.9) | 3 (50) | 0.02 |
Adenocarcinoma | 5 (35.7) | 3 (50) | |
Adenosquamous | 1 (7.1) | 0 | |
Others | 2 (14.3) | 0 | |
Initial clinical stagea | |||
IB1 | 12 (85.7) | 6 (100) | <0.001 |
IB2 | 2 (14.3) | 0 | |
Tumor size (cm)b | 3.5 (2–4) | 3.15 (2.9–4) | |
Tumor gradea | |||
Well-differentiated | 4 (28.6) | 3 (50) | 0.95 |
Moderately differentiated | 3 (21.4) | 3 (50) | |
Poorly differentiated | 7 (0.5) | 0 | |
LVSIa | 3 (21.4) | 0 | 0.09 |
PR positive | 6 (42.9) | 1 (16.7) | 0.354 |
Surgical time (min)b | 172.5 (90–195) | 120 (100–195) | 0.78 |
Blood loss (mm)b | 100 (70–300) | 140 (100–250) | 0.72 |
Blood transfusiona | 0 | 0 | NS |
Others complicationsa | 0 | 1 (16.7) | <0.001 |
Hospital stay (days)b | 2 (2–2) | 2 (2–3) | 0.44 |
Neoadjuvant treatment term (weeks)b | 10.5 (8.2–14.2) | 10.5 (8–15.4) | 0.66 |
Recurrencea | |||
Local | 0 | 1 (16.7) | <0.001 |
Regional | 3 (21.4) | 0 | |
Distance | 3 (21.4) | 0 | |